2
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Multiple Myeloma
11
Lymphoma, Non-Hodgkin
9
Lymphoma
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Leukemia, Myeloid, Acute
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Hodgkin Disease
5
Myelodysplastic Syndromes
4
Neoplasms, Plasma Cell
3
Melanoma
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Leukemia
3
Glioma
3
Carcinoma, Non-Small-Cell Lung
3
Primary Myelofibrosis
2
Ovarian Neoplasms
2
Myeloproliferative Disorders
2
Lymphoma, B-Cell
2
Immunoglobulin Light-chain Amyloidosis
2
Hematologic Neoplasms
2
Glioblastoma
2
Burkitt Lymphoma
2
Wilms Tumor
1
Triple Negative Breast Neoplasms
1
Solid Tumor
1
Sarcoma
1
Recurrence
1
Philadelphia Chromosome
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Interventions
aldesleukin
43
Sunitinib
42
Cyclophosphamide
30
Nivolumab
29
pembrolizumab
27
Everolimus
27
Interferon-alpha
25
Bevacizumab
23
Sorafenib
22
Interleukin-2
20
fludarabine phosphate
19
Radiotherapy
18
Ipilimumab
18
Filgrastim
18
Axitinib
18
Gene Expression Profiling
16
Peripheral Blood Stem Cell Transplantation
15
Gemcitabine
15
cabozantinib
14
Radiosurgery
13
fludarabine
11
Doxorubicin
11
Carboplatin
11
Blood Specimen Collection
11
temsirolimus
10
atezolizumab
9
Immunohistochemistry
9
Etoposide
9
Chemotherapy, Adjuvant
9
sargramostim
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Kidney Neoplasms
×
Blood Component Removal
×
Clear all
NCT04981119
2026-06-02
BASECAMP-1
A2 Biotherapeutics Inc.
Recruiting
200 enrolled